CIK 0001819790 · Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814717861
- Phone
- (949) 409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- 4 Open-market sale Chief Human Resources Officer sold 6,711 shares at an average $47.88 ($321,323)
- 4 Open-market sale President/CEO and Board Chair sold 24,216 shares at an average $48.03 ($1,163,050)
- 4 Open-market sale See Remarks sold 3,724 shares at an average $47.88 ($178,306)
- 4 Option exercise See Remarks acquired 8,019 shares (option exercise)
- 4 Option exercise President/CEO and Board Chair acquired 51,395 shares (option exercise)
- 4 Option exercise Chief Human Resources Officer acquired 18,885 shares (option exercise)
- 4 Option exercise General Counsel acquired 19,213 shares (option exercise)
- 4 Option exercise Chief Operating Officer acquired 21,264 shares (option exercise)
- 4 Option exercise Chief Commercial Officer acquired 20,957 shares (option exercise)
- 4 Option exercise Director acquired 7,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 5 of 17 · 330 filings